Last reviewed · How we verify
Progesterone oral capsule
At a glance
| Generic name | Progesterone oral capsule |
|---|---|
| Also known as | Progesterone |
| Sponsor | BHR Pharma, LLC |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Efficacy of Micronized Natural Progesterone vs GnRH Antagonist in the Prevention of LH Peak During Ovarian Stimulation. (PHASE4)
- Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening (PHASE4)
- Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease (PHASE3)
- A Prospective Multicenter Observational Real-world Study of Retained Products of Conception
- Multifaceted Benefits of Auricular Point Sticking for IVF Patients: Psychological Well-being, Sleep, and Treatment Outcomes (NA)
- Pilot Trial of Pregnenolone in Autism (PHASE2)
- No More Sleepless Nights in Perimenopause (PHASE4)
- Study on Allopregnanolone and Depression in Women Across the Menopause Transition (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Progesterone oral capsule CI brief — competitive landscape report
- Progesterone oral capsule updates RSS · CI watch RSS
- BHR Pharma, LLC portfolio CI